|
2024-04-10 |
2024-04-08 |
S
Sale
|
Henderson Molly
CFO and CBO
Officer
|
1,000
-3.5%
11.10
100,000
USD
|
1,000
-3.5%
|
11.10
|
100,000
USD
|
|
|
2024-03-26 |
2024-03-22 |
PS
Planned sale
|
Curran Terrie
President and Chief Executive
Executive Director
|
16,851
-3.9%
9.11
153,513
USD
|
16,851
-3.9%
|
9.11
|
153,513
USD
|
|
|
2024-01-25 |
2024-01-24 |
S
Sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
3,703,703
-49.7%
8.10
29,999,994
USD
|
3,703,703
-49.7%
|
8.10
|
29,999,994
USD
|
|
|
2024-01-22 |
2024-01-19 |
PS
Planned sale
|
Henderson Molly
CFO and CBO
Officer
|
6,307
-6.0%
7.75
48,900
USD
|
6,307
-6.0%
|
7.75
|
48,900
USD
|
|
|
2023-11-21 |
2023-11-20 |
S
Sale
|
Henderson Molly
CFO and CBO
Officer
|
2,127
-2.0%
7.24
15,403
USD
|
2,127
-2.0%
|
7.24
|
15,403
USD
|
|
|
2023-11-08 |
2023-11-08 |
B
Purchase
|
Parikh Asit
Non-Executive Director
|
2,500
+4.8%
7.80
19,500
USD
|
2,500
+4.8%
|
7.80
|
19,500
USD
|
|
|
2023-11-08 |
2023-11-07 |
B
Purchase
|
Parikh Asit
Non-Executive Director
|
4,000
+8.2%
7.76
31,040
USD
|
4,000
+8.2%
|
7.76
|
31,040
USD
|
|
|
2023-11-08 |
2023-11-06 |
B
Purchase
|
Parikh Asit
Non-Executive Director
|
1,000
+2.1%
8.04
8,040
USD
|
1,000
+2.1%
|
8.04
|
8,040
USD
|
|
|
2023-11-03 |
2023-11-01 |
S
Sale
|
Henderson Molly
CFO and CBO
Officer
|
11,681
-10.0%
8.95
104,545
USD
|
11,681
-10.0%
|
8.95
|
104,545
USD
|
|
|
2023-11-03 |
2023-11-01 |
S
Sale
|
Henderson Molly
CFO and CBO
Officer
|
811
-0.7%
7.80
6,326
USD
|
811
-0.7%
|
7.80
|
6,326
USD
|
|
|
2023-06-05 |
2023-06-02 |
PS
Planned sale
|
Henderson Molly
CFO and CBO
Officer
|
1,960
-2.8%
11.41
22,368
USD
|
1,960
-2.8%
|
11.41
|
22,368
USD
|
|
|
2023-05-23 |
2023-05-22 |
PS
Planned sale
|
Henderson Molly
CFO and CBO
Officer
|
2,110
-2.9%
12.87
27,165
USD
|
2,110
-2.9%
|
12.87
|
27,165
USD
|
|
|
2023-04-11 |
2023-04-11 |
B
Purchase
|
Nabulsi Azmi
Chief Operating Officer
Officer
|
10,000
+11.2%
8.26
82,600
USD
|
10,000
+11.2%
|
8.26
|
82,600
USD
|
|
|
2023-04-11 |
2023-04-10 |
B
Purchase
|
Parikh Asit
Non-Executive Director
|
1,000
+4.4%
7.55
7,550
USD
|
1,000
+4.4%
|
7.55
|
7,550
USD
|
|
|
2023-04-07 |
2023-04-06 |
PS
Planned sale
|
Henderson Molly
CFO and CBO
Officer
|
3,439
-4.5%
7.27
25,002
USD
|
3,439
-4.5%
|
7.27
|
25,002
USD
|
|
|
2023-04-07 |
2023-04-06 |
B
Purchase
|
Curran Terrie
President and Chief Executive
Executive Director
|
12,919
+7.4%
7.82
101,025
USD
|
12,919
+7.4%
|
7.82
|
101,025
USD
|
|
|
2023-03-03 |
2023-03-01 |
PS
Planned sale
|
Henderson Molly
CFO and CBO
Officer
|
2,032
-2.6%
8.53
17,335
USD
|
2,032
-2.6%
|
8.53
|
17,335
USD
|
|
|
2023-03-03 |
2023-03-01 |
PS
Planned sale
|
Curran Terrie
President and Chief Executive
Executive Director
|
1,436
-0.8%
8.54
12,265
USD
|
1,436
-0.8%
|
8.54
|
12,265
USD
|
|
|
2023-02-14 |
2023-02-13 |
B
Purchase
|
Parikh Asit
Non-Executive Director
|
5,000
+28.6%
7.73
38,660
USD
|
5,000
+28.6%
|
7.73
|
38,660
USD
|
|
|
2023-01-20 |
2023-01-20 |
S
Sale
|
Curran Terrie
President and Chief Executive
Executive Director
|
5,821
-3.2%
8.20
47,729
USD
|
5,821
-3.2%
|
8.20
|
47,729
USD
|
|
|
2023-01-12 |
2023-01-12 |
B
Purchase
|
Parikh Asit
Non-Executive Director
|
5,000
+40.0%
7.00
35,000
USD
|
5,000
+40.0%
|
7.00
|
35,000
USD
|
|
|
2022-11-23 |
2022-11-21 |
S
Sale
|
Henderson Molly
CFO and CBO
Officer
|
2,159
-4.7%
9.60
20,726
USD
|
2,159
-4.7%
|
9.60
|
20,726
USD
|
|
|
2022-11-23 |
2022-11-21 |
S
Sale
|
Curran Terrie
President and Chief Executive
Executive Director
|
1,526
-1.8%
9.60
14,650
USD
|
1,526
-1.8%
|
9.60
|
14,650
USD
|
|
|
2022-05-16 |
2022-05-16 |
B
Purchase
|
Nabulsi Azmi
Chief Operating Officer
Officer
|
20,000
+2.6%
8.16
163,288
USD
|
20,000
+2.6%
|
8.16
|
163,288
USD
|
|
|
2022-05-16 |
2022-05-13 |
B
Purchase
|
Henderson Molly
CFO and CBO
Officer
|
6,000
0.00
0
USD
|
6,000
|
0.00
|
0
USD
|
|
|
2022-05-16 |
2022-05-13 |
B
Purchase
|
Curran Terrie
President and Chief Executive
Executive Director
|
20,500
+46.5%
7.41
151,835
USD
|
20,500
+46.5%
|
7.41
|
151,835
USD
|
|
|
2022-05-16 |
2022-05-12 |
B
Purchase
|
Parikh Asit
Non-Executive Director
|
12,500
+inf%
8.00
100,000
USD
|
12,500
+inf%
|
8.00
|
100,000
USD
|
|
|
2022-03-16 |
2022-03-14 |
S
Sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
18
-0.0%
19.00
342
USD
|
18
-0.0%
|
19.00
|
342
USD
|
|
|
2021-11-08 |
2021-11-04 |
S
Sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
1,000,000
-90.9%
20.85
20,850,000
USD
|
1,000,000
-90.9%
|
20.85
|
20,850,000
USD
|
|
|
2021-11-08 |
2021-11-04 |
S
Sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
1
-0.0%
19.00
19
USD
|
1
-0.0%
|
19.00
|
19
USD
|
|
|
2021-10-08 |
2021-10-08 |
S
Sale
|
Socks David A
Non-Executive Director
|
2,529
-0.2%
32.05
81,052
USD
|
2,529
-0.2%
|
32.05
|
81,052
USD
|
|
|
2021-10-08 |
2021-10-07 |
PS
Planned sale
|
Socks David A
Non-Executive Director
|
15,471
-1.3%
32.66
505,343
USD
|
15,471
-1.3%
|
32.66
|
505,343
USD
|
|
|
2021-06-29 |
2021-06-29 |
S
Sale
|
Socks David A
Non-Executive Director
|
13,960
-1.1%
34.00
474,657
USD
|
13,960
-1.1%
|
34.00
|
474,657
USD
|
|
|
2021-06-29 |
2021-06-28 |
S
Sale
|
Socks David A
Non-Executive Director
|
156
-0.0%
35.09
5,474
USD
|
156
-0.0%
|
35.09
|
5,474
USD
|
|
|
2021-06-29 |
2021-06-28 |
PS
Planned sale
|
Socks David A
Non-Executive Director
|
25,884
-2.0%
34.07
881,811
USD
|
25,884
-2.0%
|
34.07
|
881,811
USD
|
|
|
2021-06-29 |
2021-06-28 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
370
-0.0%
35.08
12,980
USD
|
370
-0.0%
|
35.08
|
12,980
USD
|
|
|
2021-06-29 |
2021-06-25 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
1,250
-0.1%
36.07
45,088
USD
|
1,250
-0.1%
|
36.07
|
45,088
USD
|
|
|
2021-06-29 |
2021-06-25 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
22,881
-2.5%
35.46
811,360
USD
|
22,881
-2.5%
|
35.46
|
811,360
USD
|
|
|
2021-06-25 |
2021-06-24 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
10,848
-1.2%
35.14
381,199
USD
|
10,848
-1.2%
|
35.14
|
381,199
USD
|
|
|
2021-06-25 |
2021-06-23 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
200
-0.0%
35.00
7,000
USD
|
200
-0.0%
|
35.00
|
7,000
USD
|
|
|
2021-06-23 |
2021-06-22 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
100
-0.0%
35.00
3,500
USD
|
100
-0.0%
|
35.00
|
3,500
USD
|
|
|
2021-06-23 |
2021-06-21 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
9,294
-1.0%
35.31
328,171
USD
|
9,294
-1.0%
|
35.31
|
328,171
USD
|
|
|
2021-06-21 |
2021-06-18 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
5,398
-0.6%
35.13
189,632
USD
|
5,398
-0.6%
|
35.13
|
189,632
USD
|
|
|
2021-06-21 |
2021-06-17 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
3,305
-0.4%
35.08
115,939
USD
|
3,305
-0.4%
|
35.08
|
115,939
USD
|
|
|
2021-06-16 |
2021-06-14 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
2,826
-0.3%
35.06
99,080
USD
|
2,826
-0.3%
|
35.06
|
99,080
USD
|
|
|
2021-06-11 |
2021-06-10 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
2,102
-0.2%
35.14
73,864
USD
|
2,102
-0.2%
|
35.14
|
73,864
USD
|
|
|
2021-06-11 |
2021-06-09 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
1,191
-0.1%
35.28
42,018
USD
|
1,191
-0.1%
|
35.28
|
42,018
USD
|
|
|
2021-06-09 |
2021-06-08 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
100
-0.0%
35.00
3,500
USD
|
100
-0.0%
|
35.00
|
3,500
USD
|
|
|
2021-06-09 |
2021-06-07 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
2,264
-0.2%
35.05
79,353
USD
|
2,264
-0.2%
|
35.05
|
79,353
USD
|
|
|
2021-06-04 |
2021-06-02 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
4,300
-0.5%
35.18
151,274
USD
|
4,300
-0.5%
|
35.18
|
151,274
USD
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
3,967
-0.4%
36.20
143,605
USD
|
3,967
-0.4%
|
36.20
|
143,605
USD
|
|
|
2021-06-02 |
2021-06-01 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
7,244
-0.8%
35.55
257,524
USD
|
7,244
-0.8%
|
35.55
|
257,524
USD
|
|
|
2021-06-02 |
2021-05-28 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
2,104
-0.2%
37.55
79,005
USD
|
2,104
-0.2%
|
37.55
|
79,005
USD
|
|
|
2021-06-02 |
2021-05-28 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
2,668
-0.3%
36.40
97,115
USD
|
2,668
-0.3%
|
36.40
|
97,115
USD
|
|
|
2021-06-02 |
2021-05-28 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
4,133
-0.4%
35.37
146,184
USD
|
4,133
-0.4%
|
35.37
|
146,184
USD
|
|
|
2021-05-26 |
2021-05-25 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
548
-0.1%
36.59
20,051
USD
|
548
-0.1%
|
36.59
|
20,051
USD
|
|
|
2021-05-26 |
2021-05-25 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
10,399
-1.0%
36.16
376,028
USD
|
10,399
-1.0%
|
36.16
|
376,028
USD
|
|
|
2021-05-26 |
2021-05-24 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
1,683
-0.2%
36.10
60,756
USD
|
1,683
-0.2%
|
36.10
|
60,756
USD
|
|
|
2021-05-26 |
2021-05-24 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
8,911
-0.9%
35.58
317,053
USD
|
8,911
-0.9%
|
35.58
|
317,053
USD
|
|
|
2021-05-24 |
2021-05-21 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
11,648
-1.1%
35.74
416,300
USD
|
11,648
-1.1%
|
35.74
|
416,300
USD
|
|
|
2021-05-24 |
2021-05-20 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
7,098
-0.7%
35.10
249,140
USD
|
7,098
-0.7%
|
35.10
|
249,140
USD
|
|
|
2021-05-18 |
2021-05-14 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
100
-0.0%
35.00
3,500
USD
|
100
-0.0%
|
35.00
|
3,500
USD
|
|
|
2021-05-14 |
2021-05-13 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
100
-0.0%
35.33
3,533
USD
|
100
-0.0%
|
35.33
|
3,533
USD
|
|
|
2021-05-14 |
2021-05-12 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
905
-0.1%
36.06
32,634
USD
|
905
-0.1%
|
36.06
|
32,634
USD
|
|
|
2021-05-14 |
2021-05-12 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
10,871
-1.0%
35.39
384,725
USD
|
10,871
-1.0%
|
35.39
|
384,725
USD
|
|
|
2021-05-11 |
2021-05-07 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
1,011
-0.1%
35.03
35,415
USD
|
1,011
-0.1%
|
35.03
|
35,415
USD
|
|
|
2021-05-07 |
2021-05-06 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
202
-0.0%
35.01
7,072
USD
|
202
-0.0%
|
35.01
|
7,072
USD
|
|
|
2021-05-07 |
2021-05-05 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
6,936
-0.7%
35.14
243,731
USD
|
6,936
-0.7%
|
35.14
|
243,731
USD
|
|
|
2021-05-05 |
2021-05-04 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
100
-0.0%
38.53
3,853
USD
|
100
-0.0%
|
38.53
|
3,853
USD
|
|
|
2021-05-05 |
2021-05-04 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
3,500
-0.3%
37.47
131,145
USD
|
3,500
-0.3%
|
37.47
|
131,145
USD
|
|
|
2021-05-05 |
2021-05-04 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
4,690
-0.4%
36.21
169,825
USD
|
4,690
-0.4%
|
36.21
|
169,825
USD
|
|
|
2021-05-05 |
2021-05-04 |
PS
Planned sale
|
TAKEDA PHARMACEUTICAL CO LTD
Major owner
|
11,070
-1.0%
35.50
392,985
USD
|
11,070
-1.0%
|
35.50
|
392,985
USD
|
|
|
2021-05-04 |
2021-05-04 |
S
Sale
|
Nabulsi Azmi
Chief Operating Officer
Officer
|
1,089
-0.1%
37.86
41,231
USD
|
1,089
-0.1%
|
37.86
|
41,231
USD
|
|
|
2021-05-04 |
2021-05-04 |
S
Sale
|
Nabulsi Azmi
Chief Operating Officer
Officer
|
1,400
-0.2%
37.09
51,921
USD
|
1,400
-0.2%
|
37.09
|
51,921
USD
|
|
|
2021-05-04 |
2021-05-04 |
S
Sale
|
Nabulsi Azmi
Chief Operating Officer
Officer
|
1,968
-0.3%
36.15
71,150
USD
|
1,968
-0.3%
|
36.15
|
71,150
USD
|
|
